[1] |
Sun D, Feng J, Dai C, et al. Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy [J]. Am J Nephrol, 2006, 26(4): 363-371.
|
[2] |
Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis [J]. Kidney Int Suppl, 1998, 65:S74-S78.
|
[3] |
Zhang X, Lawler J. Thrombospondin-based antiangiogenic therapy [J]. Microvasc Res, 2007, 74(2-3): 90-99.
|
[4] |
Kaihatsu K, Braasch DA, Cansizoglu A, et al. Enhanced strand invasion by pep tide nucleic acid-peptide conjugates [J]. Biochemistry, 2002, 41(37): 11118-11125.
|
[5] |
Hugo C, Shankland SJ, Pichler RH, et al. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat [J]. Kidney Int, 1998, 53(2): 302-311.
|
[6] |
Kang DH, Joly AH, Oh SW, et al. Impaired angiogenesis in the remnant kidney model. I. Potential role of vascular endothelial growth factor and thrombospondin-1 [J]. J Am Soc Nephrol, 2001, 12(7): 1434-1447.
|
[7] |
Kida Y, Duffield JS. Pivotal role of pericytes in kidney fibrosis [J]. Clin Exp Pharmacol Physiol, 2011, 38(7): 417-423.
|
[8] |
Ohashi R, Shimizu A, Masuda Y,et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy [J]. J Am Soc Nephrol, 2002, 13(7): 1795-1805.
|
[9] |
Sun D, Ma Y, Han H, et al. Thrombospondin-1 short hairpin RNA suppresses tubulointerstitial fibrosis in the kidney of ureteral obstruction by ameliorating peritubular capillary injury [J]. Kidney Blood Press Res, 2012, 35(1): 35-47.
|
[10] |
Dawson DW, Pearce SF, Zhong R,et al. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells [J]. J Cell Biol, 1997, 138(3): 707-717.
|
[11] |
Shim Y, Nam MH, Hyuk SW, et al. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction [J]. Anal Chim Acta, 2015, 853: 501-507.
|
[12] |
Taal MW, Zandi-Nejad K, Weening B, et al. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney [J]. Kidney Int, 2000, 58(4): 1664-1667.
|
[13] |
Sambrook J, Russell D. Molecular Cloning. A Laboratory Manual[M].New York: Cold Spring Harbor Laboratory Press,2001: 463-470.
|
[14] |
Morrissey J, Klahr S. Transcription factor NF-B regulation of renal fibrosis during ureteral obstruction [J]. Semin Nephrol, 1998, 18(6): 603-611.
|
[15] |
Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1 [J]. Matrix Bio, 2000, 19(7): 597-614.
|
[16] |
Guo N, Krutzsch HC, Inman JK, et al. Thrombospondin-1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells [J]. Cancer Res, 1997, 57(9): 1735-1742.
|
[17] |
Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro [J]. Proc Natl Acad Sci USA, 1991, 88(11): 5026-5030.
|
[18] |
Chandrasekaran S, Guo NH, Rodrigues RG, et al. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98 [J]. J Biol Chem, 1999, 274(16): 11408-11416.
|